|
|
 |
Matritech Rapid Test - BladderChek NMP22 | | | General Information | |
| Vendor | | Inverness Medical International | | Item | | Matritech Rapid Test - BladderChek NMP22 | | Catalog Number | | D1200-24 | | Approval | | Sold outside the US | | Number of Tests | | 24 | | Pricing |  |  |
| | Product Description | |
| The NMP22® BladderChek® Test is the only in-office test approved by the FDA for the diagnosis of bladder cancer. The NMP22 BladderChek Test is a painless and non-invasive assay, performed on a single urine sample, that detects elevated levels of NMP22 protein. | | Go to Vendor Product Page | | Go to Vendor Website | |
| Inverness Medical International | | Customer Service: +44 (0)1234 835000 | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
